MARKET

CSLLY

CSLLY

Csl Ltd
OTCQX
75.46
-1.36
-1.77%
Closed 15:59 05/12 EDT
OPEN
75.83
PREV CLOSE
76.82
HIGH
75.83
LOW
75.44
VOLUME
20.54K
TURNOVER
1.55M
52 WEEK HIGH
106.86
52 WEEK LOW
70.48
MARKET CAP
72.80B
P/E (TTM)
26.69
1D
5D
1M
3M
1Y
5Y
1D
Aussie shares end flat as miners offset healthcare stocks, Trump comments hit pharma stocks
Reuters · 17h ago
BUZZ-Australia's healthcare stocks drop as Trump plans executive order to cut prescription drug prices
Reuters · 19h ago
Invesco Oppenheimer International Growth Fund Q1 2025 Commentary
Seeking Alpha · 1d ago
Invesco EQV International Equity Fund Q1 2025 Commentary
Seeking Alpha · 3d ago
BUZZ-Australian healthcare stocks at 1-week low on fears of hit to exports to US
Reuters · 5d ago
Weekly Report: what happened at CSLLY last week (0428-0502)?
Weekly Report · 05/05 11:06
Trump administration said to be investing $500M on developing universal vaccines
Seeking Alpha · 05/01 09:12
CSL VIFOR AND TRAVERE THERAPEUTICS ANNOUNCE STANDARD EU APPROVAL FOR FILSPARI® IN IGA NEPHROPATHY
Reuters · 04/29 06:01
More
About CSLLY
CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The Company operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

Webull offers CSL Ltd stock information, including OTCQX: CSLLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSLLY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSLLY stock methods without spending real money on the virtual paper trading platform.